ARVINAS, INC. Debt Securities, Available-for-sale, Gain (Loss)
ARVINAS, INC. (ARVN) reported Debt Securities, Available-for-sale, Gain (Loss) of -$900.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-07.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleGainLoss · last filed 2023-11-07
- ARVINAS, INC. debt securities, available-for-sale, gain (loss) for the quarter ending 2023-09-30 was $0.00.
- ARVINAS, INC. debt securities, available-for-sale, gain (loss) for the quarter ending 2023-06-30 was $0.00.
- ARVINAS, INC. debt securities, available-for-sale, gain (loss) for the quarter ending 2023-03-31 was -$900.00K.
- ARVINAS, INC. debt securities, available-for-sale, gain (loss) for the quarter ending 2022-09-30 was -$300.00K.
| Period end | Debt Securities, Available-for-sale, Gain (Loss) 3 month | Debt Securities, Available-for-sale, Gain (Loss) 6 month | Debt Securities, Available-for-sale, Gain (Loss) 9 month |
|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | -$900.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$900.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | -$900.00K 10-Q · filed 2023-05-05 | ||
| 2022-09-30 | -$300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$400.00K derived: sum of 2 quarters · filed 2023-11-07 | -$400.00K 10-Q · filed 2023-11-07 |
| 2022-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$100.00K 10-Q · filed 2023-08-08 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-05 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |